HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caroline Truntzer Selected Research

Chemokine CCL20

1/2022Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caroline Truntzer Research Topics

Disease

38Neoplasms (Cancer)
01/2024 - 07/2010
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2019
7Breast Neoplasms (Breast Cancer)
06/2023 - 01/2018
5Neoplasm Metastasis (Metastasis)
04/2023 - 05/2018
4Glioblastoma (Glioblastoma Multiforme)
05/2024 - 10/2016
4Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 11/2018
3Genomic Instability
03/2022 - 08/2021
3Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 08/2020
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2022
3Lung Neoplasms (Lung Cancer)
01/2019 - 11/2018
2Brain Neoplasms (Brain Tumor)
05/2024 - 01/2023
2Carcinoma (Carcinomatosis)
02/2022 - 08/2021
2Melanoma (Melanoma, Malignant)
01/2022 - 08/2020
2COVID-19
01/2022 - 01/2021
2Adenocarcinoma
04/2021 - 05/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2020 - 05/2018
1Triple Negative Breast Neoplasms
06/2023
1Turcot syndrome
04/2023
1Infections
01/2022
1Carcinogenesis
01/2022
1Oncogene Addiction
11/2021
1Hypertension (High Blood Pressure)
10/2020
1Heart Failure
10/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2020
1Prostatic Neoplasms (Prostate Cancer)
08/2020
1Disease Progression
08/2020
1Endometrial Neoplasms (Endometrial Cancer)
08/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Splenomegaly
05/2018
1Glaucoma
10/2017
1Gliosis
10/2017

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
10/2023 - 07/2010
13Immune Checkpoint InhibitorsIBA
10/2023 - 01/2019
3RNA (Ribonucleic Acid)IBA
10/2023 - 10/2018
3Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2023 - 08/2020
3Programmed Cell Death 1 ReceptorIBA
01/2023 - 01/2020
3atezolizumabIBA
10/2022 - 01/2019
3LigandsIBA
01/2022 - 01/2020
3AntibodiesIBA
01/2022 - 01/2021
3Monoclonal AntibodiesIBA
06/2021 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
02/2023 - 03/2022
2PlatinumIBA
02/2023 - 03/2022
2tremelimumabIBA
01/2023 - 08/2020
2durvalumabIBA
01/2023 - 08/2020
2Bevacizumab (Avastin)FDA Link
12/2022 - 10/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2022
2folfirinoxIBA
04/2021 - 05/2018
2NivolumabIBA
01/2019 - 01/2019
2LipidsIBA
10/2017 - 01/2016
1Pyruvate KinaseIBA
10/2023
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2023
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2023
1SaltsIBA
02/2023
1trastuzumab deruxtecanIBA
01/2023
1tucatinibIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1Cell Adhesion Molecule-1IBA
01/2023
1Netrin-1IBA
01/2023
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2022
1SuspensionsIBA
10/2022
1nintedanibIBA
02/2022
1Carboplatin (JM8)FDA LinkGeneric
02/2022
1Paclitaxel (Taxol)FDA LinkGeneric
02/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Cancer VaccinesIBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1B7-H1 AntigenIBA
01/2022
1prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1Interleukin-4 (Interleukin 4)IBA
01/2022
1CytokinesIBA
01/2022
1Chemokine CCL20IBA
01/2022
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
01/2022
1Chemokine CXCL10IBA
01/2022
1Diacylglycerol O-AcyltransferaseIBA
01/2022
1Protein Kinase InhibitorsIBA
01/2022
1NucleotidesIBA
11/2021
1AntigensIBA
11/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2020
1olaparibIBA
08/2020
1IpilimumabIBA
01/2019
1pembrolizumabIBA
01/2019
1Galectins (Galectin)IBA
01/2019
1Calbindin 2IBA
01/2018
124-hydroxycholesterolIBA
10/2017
1Retinaldehyde (Retinal)IBA
10/2017
1CholesterolIBA
10/2017

Therapy/Procedure

18Therapeutics
01/2024 - 10/2018
10Immunotherapy
05/2024 - 10/2018
8Drug Therapy (Chemotherapy)
01/2023 - 11/2018
3Chemoradiotherapy
05/2024 - 10/2016
2Neoadjuvant Therapy
11/2022 - 11/2018
2Precision Medicine
08/2020 - 11/2018
1Adjuvant Chemotherapy
01/2024